Press Clipping / Oct 28, 2025
Oct. 28 Business Watch: More plants closing in Europe, Novartis to pay $12 billion for biotech firm
C&EN, 28 October 2025
Oops! Your browser version is not supported by our website.
Please use these following browsers to view this page:
C&EN, 28 October 2025
EFCG/CEFIC, 28 April 2006
Irish Examiner, November 16, 2018
Effective May 1st, 2020
Hovione is a Contract Development and Manufacturing Company dedicated to helping Pharmaceutical Customers bring new and off-patent drugs to market.
Hovione has achieved Top Employer certification across all four of its manufacturing sites worldwide for the fourth consecutive year.
on the occasion of his visit to Hovione on 21st February 2001